Blog Archives
ERN EURO-NMD webinar, Prof. Dr. Annemieke Aartsma-Rus (The Netherlands)
Genetic therapies and therapy developments for muscular dystrophies (DMD, LGMD) Wednesday 29 May 2024 – 16:00 – 17:00 Paris time Prof. Dr. Annemieke Aartsma-Rus (Leiden University Medical Center, The Netherlands) Gene Therapy webinar series Organised by EURO-NMD in collaboration with ERN-RND.
Results of a phase I gene therapy trial in giant axon neuropathy
The dose escalation trial evaluated the effects of a single intrathecal injection of four escalating doses of scAAV9/JeT-GAN in 14 patients over the age of six with GAN-related giant axon neuropathy. There were very few serious side-effects attributable to the treatment during the trial’s average follow-up of five and a half years. One of the … [Read more]
The importance of developing strategies to manage altered facial expression in FSH
Facial impairment is present in 75% of people with facioscapulohumeral muscular dystrophy (FSHD), and represents a significant psychosocial burden for a third. Given this distress, a team of Dutch clinicians looked at the treatments and psychosocial interventions used in FSHD and other pathologies where facial expression is impaired, such as facial paralysis, Moebius syndrome, myotonic … [Read more]
Real-life follow-up of 29 Pompe disease patients treated with Nexviadyme
Using the French Pompe disease registry, data from 29 patients treated with Nexviadyme after loss of efficacy with Myozyme were analyzed. After at least one year of treatment, the average deterioration in motor skills was reduced, while respiratory impairment did not progress. At individual level, there may be different responses to Nexviadyme: motor or respiratory … [Read more]
Ultrasound versus MRI for FSHD
A comparison five years apart of ultrasound and MRI scans of five leg muscles from 20 people with facioscapulohumeral muscular dystrophy (FSHD), aged between 35 and 77, showed that: 95% had FSHD type 1, one person had FSHD type 2; 90% of patients were symptomatic; 17% of initially normal muscles had an increase in their … [Read more]
Identification of numerous variants on genes involved in mitochondrial diseases in peripheral neuropathies without genetic diagnosis
British researchers have re-examined the genomic analyses of 2,087 people registered on the Genome-Phenome Analysis Platform (GPAP) with possible peripheral neuropathy. They looked for variants in 183 genes involved in mitochondrial diseases. They identified 1,379 rare variants, mainly in nuclear genes. Of these, 44 variants were already recognized as pathogenic. The genes most frequently affected … [Read more]
SNUPN joins the list of genes involved in muscular dystrophies
Two independent international studies, published and also presented at Myology 2024, have reported the involvement of the SNUPN gene in a new form of muscular dystrophy. Like LAMA2, SNUPN is thought to be responsible for a congenital form (CMD) presenting before the age of two, and a later form which could be the 29th recessive … [Read more]
Can a simple blood count predict a myasthenic crisis?
According to a retrospective study conducted in Germany on 15 patients who had suffered a total of 21 myasthenic attacks and 43 patients who had not suffered any: an increase in basophils, neutrophils, total leucocytes and platelets was associated with a higher risk of myasthenic attacks, conversely, other haemogram parameters, CRP levels, sex and type … [Read more]
A large Iranian cohort of patients with COL-Q deficiency
Iranian clinicians report on a large cohort of 26 patients followed for an average of nine years and in whom the diagnosis of congenital myasthenic syndrome (CMS) with COLQ deficiency has been formally proven: the clinical, electrophysiological and molecular data of these patients were compiled, signs of onset usually consisted of ptosis, ophthalmoparesis and limb-girdle … [Read more]
A look back at Myology 2024
More than 1,100 myology specialists and nearly 90 speakers came together at Myology 2024, the international scientific congress dedicated to muscle science and medicine. Organised by the AFM-Téléthon, it was held in Paris from 22 to 25 April 2024. The richness of the Myology 2024 programme testifies to the dynamism of research in myology and the … [Read more]
